Literature DB >> 3284272

Mechanisms of brain damage in focal cerebral ischemia.

M Nedergaard1.   

Abstract

Ischemic stroke is a major disabling disease. There are 500,000 new cases in U.S. every year, and the middle cerebral artery (MCA) is the artery most often occluded. In this paper recent results of experimental MCA occlusion are reviewed, with special emphasis on those factors contributing to irreversible damage. Occlusion of MCA in the rat causes a pronounced decline of flow in the neostriatum to less than 10% of normal. The area of low flow is surrounded by a zone 0.2-0.5 mm wide, across which blood flow increases steeply. Beyond this zone, changes in flow are more gradual, and perfusion is reduced to about 1/3 of normal in the adjacent ipsilateral cortex. The MCA occlusion leads to a sharply demarcated infarct and to scattered neuronal injury in the adjacent cortical tissue. It is suggested that the ischemic core is identical with the tissue infarct, i.e. that it is the initial pattern of blood flow which determines the volume and topography of infarction. Waves of spreading depression are detected in the cortical low perfusion area during the first hours of MCA occlusion, and glucose consumption is increased, presumably due to an increased demand for ionic transport. In hyperglycemic animals, the number of spreading depressions is reduced as is the glucose consumption. The repeated waves of spreading depression in combination with partial energy depletion may induce selective neuronal injury in the peri-infarct zone, a suggestion which finds support in the fact that hyperglycemia ameliorates neuronal injury around the infarction.

Entities:  

Mesh:

Year:  1988        PMID: 3284272     DOI: 10.1111/j.1600-0404.1988.tb05878.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  22 in total

1.  Anesthesiology: glucose administration during neurosurgical procedures.

Authors:  B M Wiele
Journal:  West J Med       Date:  1990-09

2.  Post-ischemic alterations in [3H]FK506 binding in the gerbil and rat brains.

Authors:  T Araki; H Kato; K Shuto; Y Itoyama
Journal:  Metab Brain Dis       Date:  1998-03       Impact factor: 3.584

3.  The use of spreading depression waves for acute and long-term monitoring of the penumbra zone of focal ischemic damage in rats.

Authors:  V I Koroleva; J Bures
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

4.  Dendritic phosphorescent probes for oxygen imaging in biological systems.

Authors:  Artem Y Lebedev; Andrei V Cheprakov; Sava Sakadzić; David A Boas; David F Wilson; Sergei A Vinogradov
Journal:  ACS Appl Mater Interfaces       Date:  2009-06       Impact factor: 9.229

5.  The heterogeneous temporal evolution of focal ischemic neuronal damage in the rat.

Authors:  M O Dereski; M Chopp; R A Knight; L C Rodolosi; J H Garcia
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 6.  Opposing effects of glucose on stroke and reperfusion injury: acidosis, oxidative stress, and energy metabolism.

Authors:  Nathaniel M Robbins; Raymond A Swanson
Journal:  Stroke       Date:  2014-04-17       Impact factor: 7.914

Review 7.  Pathophysiology of the ischemic penumbra--revision of a concept.

Authors:  T Back
Journal:  Cell Mol Neurobiol       Date:  1998-12       Impact factor: 5.046

8.  Silver impregnability of ischemia-sensitive neocortical neurons after 15 minutes of cardiac arrest in the dog.

Authors:  I Vanický; M Marsala; J Orendácová; J Marsala
Journal:  Anat Embryol (Berl)       Date:  1992-07

9.  Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat.

Authors:  J H Garcia; Y Yoshida; H Chen; Y Li; Z G Zhang; J Lian; S Chen; M Chopp
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

10.  Induction of FOS and JUN proteins after focal ischemia in the rat: differential effect of the N-methyl-D-aspartate receptor antagonist MK-801.

Authors:  P Gass; M Spranger; T Herdegen; R Bravo; P Köck; W Hacke; M Kiessling
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.